HopeStage
Back to all studies
CompletedNCT04760652

CBT after esketamine for depression and suicidal thoughts

About this title

Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention

Read the official source — NCT04760652
Behavioural studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Birmingham and 2 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: March 5, 2021
Recruitment status
Completed
Enrollment listed in the registry
93
Sponsor
Yale University
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Other
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT04760652
Official title
Show the full official title

CBT-ENDURE: Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham · New Haven · Atlanta

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies